Santhera Pharmaceuticals Holding AG (SIX: SANN), a Swiss based company announced that they will present data from an on-going Expanded Access Program (EAP) for their… Read More »LHON treatment results scheduled for up-coming neuro-ophthalmology meeting
Researchers based at Pfizer’s Ophthalmology External Research Unit in San Diego, have published supporting animal data showing that a clinical stage siRNA experimental drug (PF-04523655)… Read More »Pre-clinical siRNA data shows targeting of stress response gene may have therapeutic benefit for CNV
Syncona LLP, an independent subsidiary of the Wellcome Trust, the University of Oxford, and its technology transfer arm, Isis Innovations, have announced a £12 million… Read More »New retinal gene therapy company, NightstaRx Ltd, is spun out of University of Oxford with £12M venture funding
Alimera Sciences, Inc. (NASDAQ: ALIM), Alpharetta, GA, has announced the receipt of a recommendation decision from the Scottish Medicine’s Board for the restricted use of… Read More »Iluvien fluocinolone approved by the Scottish Medicines Board for restricted use on the NHS
Researchers based at the Department of Cell Biology, University of Oklahoma Health Sciences Center and the John A. Moran Eye Center, University of Utah, have… Read More »Thyroid hormone (TH) signaling may play a significant role in retinal disorders of both degeneration and proliferation
A Seattle-based company, Acucela Inc., has raised $162.4M through the sale of 9.2M shares on the Tokyo Stock Exchange (TSE). The company was originally founded… Read More »Seattle based company, Acucela Inc., with lead geographic atrophy compound raises $162M in IPO.
Two-year clinical trial results from a Phase III study, announced by Regeneron Pharmaceuticals Inc., show that injection of 2 mg of Eylea aflibercept, in patients… Read More »Two-year Phase III data indicates that VEGF Trap-Eye (Eylea aflibercept) has sustained benefit in treatment of diabetic macular edema (DME)
Researchers based at the Department of Ophthalmology, Seoul National University College of Medicine, Korea, suggest that preliminary results from an investigation of the feasibility of… Read More »Computerised colour vision test may aid in screening for diabetic macular edema
French company Nicox S.A. (Euronext: COX) has announced that affiliate companies of itself and Sequenom Inc (Nicox Inc. and Sequenom Laboratories) have entered into an… Read More »French company, Nicox S.A. (Euronext: COX) announce grant of exclusive North American rights to Sequenom’s RetnaGene AMD test.
A Swiss based company, Santhera Pharmaceuticals Holding AG (SIX: SANN), has reported that the French National Agency for Medicines and Health Products Safety (ANSM) has… Read More »Temporary authorisation is provided by French national regulatory agency (ANSM) for novel LHON treatment